Newstral
Stephen Salloway
- In quiet debut, Alzheimer’s drug finds questions, skepticismThe Fresno Bee
- In quiet debut, Alzheimer's drug finds questions, skepticismlasvegassun.com
- Biogen’s New Alzheimer’s Drug Beyond Reach for Many Patientswsj.com
- BFDA approval of new Alzheimer’s drug Aduhelm, developed in part by Brown researchers, mired in controversybrowndailyherald.com
- First patient given controversial new Alzheimer’s treatment drugNew York Post
- First patient receives controversial Biogen Alzheimer’s drugSydney Morning Herald
- BBrown’s new Center for Alzheimer’s Disease Research to expand studies on prevention, treatment methodsbrowndailyherald.com
- BBrown researchers to start clinical trial funded by Alzheimer’s Associationbrowndailyherald.com
- BU. Professor integrates use of spinal taps in Alzheimer’s diagnosisbrowndailyherald.com
- Hopes rise again for a drug to slow Alzheimer's diseaseWBNS-10TV
- Hopes rise again for a drug to slow Alzheimer’s disease - Wed, 25 Jul 2018 PSTThe Spokesman-Review
- James P. McLaughlinvalleybreeze.com
- James P. McLaughlin - Cumberlandvalleybreeze.com
- Another failure in search for treatment to slow Alzheimer’skentucky.com
- HAnother Failure in Search For Treatment to Slow Alzheimer’shamodia.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.